{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:54:24Z","timestamp":1793498064488,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-022-03205-6","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T13:02:38Z","timestamp":1664888558000},"page":"580-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparison of plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8861-8803","authenticated-orcid":false,"given":"Mojca","family":"Jensterle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Podbregar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6594-5254","authenticated-orcid":false,"given":"Andrej","family":"Jane\u017e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8044-3527","authenticated-orcid":false,"given":"Matej","family":"Rakusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Goricar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1301-632X","authenticated-orcid":false,"given":"Katja","family":"Prok\u0161elj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"issue":"5","key":"3205_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/00004872-199405000-00015","volume":"12","author":"GH Anderson Jr","year":"2014","unstructured":"G.H. Anderson Jr, N. Blakeman, D.H. Streeten, The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J. Hypertens. 12(5), 609\u2013615 (2014). https:\/\/doi.org\/10.1097\/00004872-199405000-00015","journal-title":"J. Hypertens."},{"issue":"6","key":"3205_CR2","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"J.W. Lenders, Q.Y. Duh, G. Eisenhofer, A.P. Gimenez-Roqueplo, S.K. Grebe et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(6), 1915\u20131942 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1498","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3205_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2478\/enr-2019-0020","volume":"53","author":"FA Farrugia","year":"2019","unstructured":"F.A. Farrugia, A. Charalampopoulos, Pheochromocytoma. Endocr. Regul. 53(3), 191\u2013212 (2019). https:\/\/doi.org\/10.2478\/enr-2019-0020","journal-title":"Endocr. Regul."},{"issue":"11","key":"3205_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1373\/clinchem.2018.291369","volume":"64","author":"G Eisenhofer","year":"2018","unstructured":"G. Eisenhofer, A. Prejbisz, M. Peitzsch, C. Pamporaki, J. Masjkur et al. Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites. Clin. Chem. 64(11), 646\u2013656 (2018). https:\/\/doi.org\/10.1373\/clinchem.2018.291369","journal-title":"Clin. Chem."},{"issue":"3","key":"3205_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1530\/EJE-15-0651","volume":"174","author":"SW Olson","year":"2016","unstructured":"S.W. Olson, S. Yoon, T. Baker, L.K. Prince, D. Oliver et al. Longitudinal plasma metanephrines preceding pheochromocytoma diagnosis: a retrospective case-control serum repository study. Eur. J. Endocrinol. 174(3), 289\u2013295 (2016). https:\/\/doi.org\/10.1530\/EJE-15-0651","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"3205_CR6","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/archinte.1987.00370070103015","volume":"147","author":"AM Sinclair","year":"1987","unstructured":"A.M. Sinclair, C.G. Isles, I. Brown, H. Cameron, G.D. Murray et al. Secondary hypertension in a blood pressure clinic. Arch. Intern Med. 147(7), 1289\u20131293 (1987)","journal-title":"Arch. Intern Med."},{"issue":"3","key":"3205_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4158\/EP.6.3.249","volume":"6","author":"M Ariton","year":"2000","unstructured":"M. Ariton, C.S. Juan, T.W. AvRuskin, Pheochromocytoma: clinical observations from a Brooklyn tertiary hospital. Endocr. Pr. 6(3), 249\u2013252 (2000). https:\/\/doi.org\/10.4158\/EP.6.3.249","journal-title":"Endocr. Pr."},{"issue":"3","key":"3205_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1291\/hypres.27.193","volume":"27","author":"M Omura","year":"2004","unstructured":"M. Omura, J. Saito, K. Yamaguchi, Y. Kakuta, T. Nishikawa, Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens. Res. 27(3), 193\u2013202 (2004). https:\/\/doi.org\/10.1291\/hypres.27.193","journal-title":"Hypertens. Res."},{"issue":"2","key":"3205_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1210\/jcem.85.2.6372","volume":"85","author":"F Mantero","year":"2000","unstructured":"F. Mantero, M. Terzolo, G. Arnaldi, G. Osella, A.M. Masini et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85(2), 637\u2013644 (2000). https:\/\/doi.org\/10.1210\/jcem.85.2.6372","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3205_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/er.2002-0031","volume":"25","author":"G Mansmann","year":"2004","unstructured":"G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr. Rev. 25(2), 309\u2013340 (2004). https:\/\/doi.org\/10.1210\/er.2002-0031","journal-title":"Endocr. Rev."},{"issue":"2","key":"3205_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"L. Fishbein, I. Leshchiner, V. Walter, L. Danilova, A.G. Robertson et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 31(2), 181\u2013193 (2017). https:\/\/doi.org\/10.1016\/j.ccell.2017.01.001","journal-title":"Cancer Cell."},{"issue":"5","key":"3205_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1055\/s-0031-1301302","volume":"44","author":"AP Gimenez-Roqueplo","year":"2012","unstructured":"A.P. Gimenez-Roqueplo, P.L. Dahia, M. Robledo, An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm. Metab. Res. 44(5), 328\u2013333 (2012). https:\/\/doi.org\/10.1055\/s-0031-1301302","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"3205_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/MED.0000000000000059","volume":"21","author":"HQ Rana","year":"2014","unstructured":"H.Q. Rana, I.R. Rainville, A. Vaidya, Genetic testing in the clinical care of patients with pheochromocytoma and paraganglioma. Curr. Opin. Endocrinol. Diabetes Obes. 21(3), 166\u2013176 (2014). https:\/\/doi.org\/10.1097\/MED.0000000000000059","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"2","key":"3205_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1297\/cpe.25.59","volume":"25","author":"K Yamamoto","year":"2016","unstructured":"K. Yamamoto, N. Namba, T. Kubota, T. Usui, K. Takahashi et al. Pheochromocytoma complicated by cyanotic congenital heart disease: a case report. Clin. Pediatr. Endocrinol. 25(2), 59\u201365 (2016). https:\/\/doi.org\/10.1297\/cpe.25.59","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"3205_CR15","doi-asserted-by":"publisher","unstructured":"Ogasawara T., Fujii Y., Kakiuchi N., Shiozawa Y., Sakamoto R., et al. Genetic analysis of pheochromocytoma and paraganglioma complicating cyanotic congenital heart disease [published online ahead of print, 2022 Jun 22]. J. Clin. Endocrinol. Metab. 2022;dgac362. https:\/\/doi.org\/10.1210\/clinem\/dgac362","DOI":"10.1210\/clinem\/dgac362"},{"issue":"2","key":"3205_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/s0046-8177(73)80012-7","volume":"4","author":"MJ Saldana","year":"1973","unstructured":"M.J. Saldana, L.E. Salem, R. Travezan, High altitude hypoxia and chemodectomas. Hum. Pathol. 4(2), 251\u2013263 (1973). https:\/\/doi.org\/10.1016\/s0046-8177(73)80012-7","journal-title":"Hum. Pathol."},{"issue":"21","key":"3205_CR17","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.jacc.2011.08.025","volume":"58","author":"D van der Linde","year":"2011","unstructured":"D. van der Linde, E.E. Konings, M.A. Slager, M. Witsenburg, W.A. Helbing et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 58(21), 2241\u20132247 (2011). https:\/\/doi.org\/10.1016\/j.jacc.2011.08.025","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"3205_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/ije\/dyz009","volume":"48","author":"Y Liu","year":"2019","unstructured":"Y. Liu, S. Chen, L. Z\u00fchlke, G.C. Black, M.K. Choy et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int J. Epidemiol. 48(2), 455\u2013463 (2019). https:\/\/doi.org\/10.1093\/ije\/dyz009","journal-title":"Int J. Epidemiol."},{"issue":"113","key":"3205_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1183\/09059180.00003309","volume":"18","author":"MA Gatzoulis","year":"2009","unstructured":"M.A. Gatzoulis, R. Alonso-Gonzalez, M. Beghetti, Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease. Eur. Respir. Rev. 18(113), 154\u2013161 (2009). https:\/\/doi.org\/10.1183\/09059180.00003309","journal-title":"Eur. Respir. Rev."},{"issue":"4","key":"3205_CR20","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1210\/jc.2014-3863","volume":"100","author":"AR Opotowsky","year":"2015","unstructured":"A.R. Opotowsky, L.E. Moko, J. Ginns, M. Rosenbaum, M. Greutmann et al. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease. J. Clin. Endocrinol. Metab. 100(4), 1325\u20131334 (2015). https:\/\/doi.org\/10.1210\/jc.2014-3863","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"3205_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1291\/hypres.26.433","volume":"26","author":"T Kita","year":"2003","unstructured":"T. Kita, T. Imamura, H. Date, K. Kitamura, S. Moriguchi et al. Two cases of pheochromocytoma associated with tetralogy of Fallot. Hypertens. Res. 26(5), 433\u2013437 (2003). https:\/\/doi.org\/10.1291\/hypres.26.433","journal-title":"Hypertens. Res."},{"issue":"9","key":"3205_CR22","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1373\/clinchem.2007.087114","volume":"53","author":"WH de Jong","year":"2007","unstructured":"W.H. de Jong, K.S. Graham, J.C. van der Molen, T.P. Links, M.R. Morris et al. Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry. Clin. Chem. 53(9), 1684\u20131693 (2007). https:\/\/doi.org\/10.1373\/clinchem.2007.087114","journal-title":"Clin. Chem."},{"issue":"2-3","key":"3205_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0034-5687(00)00125-0","volume":"121","author":"PG Guyenet","year":"2000","unstructured":"P.G. Guyenet, Neural structures that mediate sympathoexcitation during hypoxia. Respir. Physiol. 121(2-3), 147\u2013162 (2000). https:\/\/doi.org\/10.1016\/S0034-5687(00)00125-0","journal-title":"Respir. Physiol."},{"issue":"3","key":"3205_CR24","doi-asserted-by":"publisher","first-page":"C490","DOI":"10.1152\/ajpcell.2000.278.3.C490","volume":"278","author":"I Vicario","year":"2000","unstructured":"I. Vicario, R. Rigual, A. Obeso, C. Gonzalez, Characterization of the synthesis and release of catecholamine in the rat carotid body in vitro. Am. J. Physiol. Cell Physiol. 278(3), C490\u2013C499 (2000). https:\/\/doi.org\/10.1152\/ajpcell.2000.278.3.C490","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2 Pt 2","key":"3205_CR25","doi-asserted-by":"publisher","first-page":"R368","DOI":"10.1152\/ajpregu.1992.263.2.R368","volume":"263","author":"SW Mifflin","year":"1992","unstructured":"S.W. Mifflin, Arterial chemoreceptor input to nucleus tractus solitarius. Am. J. Physiol. 263(2 Pt 2), R368\u2013R375 (1992). https:\/\/doi.org\/10.1152\/ajpregu.1992.263.2.R368","journal-title":"Am. J. Physiol."},{"issue":"6","key":"3205_CR26","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1161\/01.HYP.0000101691.12358.26","volume":"42","author":"AS Hui","year":"2003","unstructured":"A.S. Hui, J.B. Striet, G. Gudelsky, G.K. Soukhova, E. Gozal et al. Regulation of catecholamines by sustained and intermittent hypoxia in neuroendocrine cells and sympathetic neurons. Hypertension 42(6), 1130\u20131136 (2003). https:\/\/doi.org\/10.1161\/01.HYP.0000101691.12358.26","journal-title":"Hypertension"},{"issue":"5-6","key":"3205_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s004210000239","volume":"82","author":"F Fischetti","year":"2000","unstructured":"F. Fischetti, B. Fabris, M. Zaccaria, A. Biagi, M. Calci et al. Effects of prolonged high-altitude exposure on peripheral adrenergic receptors in young healthy volunteers. Eur. J. Appl. Physiol. 82(5-6), 439\u2013445 (2000). https:\/\/doi.org\/10.1007\/s004210000239","journal-title":"Eur. J. Appl. Physiol."},{"issue":"1-2","key":"3205_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/BF00262813","volume":"73","author":"G Strobel","year":"1996","unstructured":"G. Strobel, M. Neureither, P. B\u00e4rtsch, Effect of acute mild hypoxia during exercise on plasma free and sulphoconjugated catecholamines. Eur. J. Appl Physiol. Occup. Physiol. 73(1-2), 82\u201387 (1996). https:\/\/doi.org\/10.1007\/BF00262813","journal-title":"Eur. J. Appl Physiol. Occup. Physiol."},{"issue":"2","key":"3205_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1042\/cs0790155","volume":"79","author":"MS Balter","year":"1990","unstructured":"M.S. Balter, K.R. Chapman, M.R. Maleki-Yazdi, F.H. Leenen, A.S. Rebuck, Effects of oxygen withdrawal on catecholamine release in patients on home oxygen therapy. Clin. Sci. (Lond.) 79(2), 155\u2013159 (1990). https:\/\/doi.org\/10.1042\/cs0790155","journal-title":"Clin. Sci. (Lond.)"},{"issue":"8","key":"3205_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.rec.2016.09.036","volume":"70","author":"I Ponz de Antonio","year":"2017","unstructured":"I. Ponz de Antonio, J. Ruiz Cantador, A.E. Gonz\u00e1lez Garc\u00eda, J.M. Oliver Ruiz, \u00c1. S\u00e1nchez-Recalde, et al., Prevalence of Neuroendocrine Tumors in Patients With Cyanotic Congenital. Heart Dis. Rev. espanola de. cardiologia (Engl. ed.) 70(8), 673\u2013675 (2017). https:\/\/doi.org\/10.1016\/j.rec.2016.09.036","journal-title":"Heart Dis. Rev. espanola de. cardiologia (Engl. ed.)"},{"key":"3205_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fendo.2018.00165","volume":"9","author":"B Zhao","year":"2018","unstructured":"B. Zhao, Y. Zhou, Y. Zhao, Y. Zhao, X. Wu et al. Co-Occurrence of Pheochromocytoma-Paraganglioma and Cyanotic Congenital Heart Disease: A Case Report and Literature Review. Front Endocrinol. (Lausanne) 9, 165 (2018). https:\/\/doi.org\/10.3389\/fendo.2018.00165","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"3-4","key":"3205_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000457479","volume":"150","author":"D Amorim-Pires","year":"2016","unstructured":"D. Amorim-Pires, J. Peixoto, J. Lima, Hypoxia Pathway Mutations in Pheochromocytomas and Paragangliomas. Cytogenet Genome Res. 150(3-4), 227\u2013241 (2016). https:\/\/doi.org\/10.1159\/000457479","journal-title":"Cytogenet Genome Res."},{"issue":"13","key":"3205_CR33","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1056\/NEJMc1716652","volume":"378","author":"A Vaidya","year":"2018","unstructured":"A. Vaidya, S.K. Flores, Z.M. Cheng, M. Nicolas, Y. Deng et al. EPAS1 Mutations and Paragangliomas in Cyanotic Congenital Heart Disease. N. Eng. J. Med. 378(13), 1259\u20131261 (2018). https:\/\/doi.org\/10.1056\/NEJMc1716652","journal-title":"N. Eng. J. Med."},{"issue":"7","key":"3205_CR34","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/ajhp\/55.7.676","volume":"55","author":"CM White","year":"1998","unstructured":"C.M. White, Catecholamines and their blockade in congestive heart failure. Am. J. Health Syst. Pharm. 55(7), 676\u2013682 (1998). https:\/\/doi.org\/10.1093\/ajhp\/55.7.676","journal-title":"Am. J. Health Syst. Pharm."},{"key":"3205_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1353.001","volume":"1073","author":"WM Manger","year":"2006","unstructured":"W.M. Manger, An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges. Ann. N. Y. Acad. Sci. 1073, 1\u201320 (2006). https:\/\/doi.org\/10.1196\/annals.1353.001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11","key":"3205_CR36","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2165\/00002018-200730110-00004","volume":"30","author":"G Eisenhofer","year":"2007","unstructured":"G. Eisenhofer, G. Rivers, A.L. Rosas, Z. Quezado, W.M. Manger et al. Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. Drug Saf. 30(11), 1031\u20131062 (2007). https:\/\/doi.org\/10.2165\/00002018-200730110-00004","journal-title":"Drug Saf."},{"issue":"1","key":"3205_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3121\/cmr.2.1.59","volume":"2","author":"DJ Myklejord","year":"2004","unstructured":"D.J. Myklejord, Undiagnosed pheochromocytoma: the anesthesiologist nightmare. Clin. Med. Res. 2(1), 59\u201362 (2004). https:\/\/doi.org\/10.3121\/cmr.2.1.59","journal-title":"Clin. Med. Res."},{"issue":"11","key":"3205_CR38","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1097\/HJH.0b013e32834a4ce9","volume":"29","author":"A Prejbisz","year":"2011","unstructured":"A. Prejbisz, J.W. Lenders, G. Eisenhofer, A. Januszewicz, Cardiovascular manifestations of phaeochromocytoma. J. Hypertens. 29(11), 2049\u20132060 (2011). https:\/\/doi.org\/10.1097\/HJH.0b013e32834a4ce9","journal-title":"J. Hypertens."},{"issue":"3","key":"3205_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1530\/EJE-14-0730","volume":"172","author":"D Weismann","year":"2015","unstructured":"D. Weismann, M. Peitzsch, A. Raida, A. Prejbisz, M. Gosk et al. Measurements of plasma metanephrines by immunoassay vs liquid chromatography with tandem mass spectrometry for diagnosis of pheochromocytoma. Eur. J. Endocrinol. 172(3), 251\u2013260 (2015). https:\/\/doi.org\/10.1530\/EJE-14-0730","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"3205_CR40","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","volume":"38","author":"JWM Lenders","year":"2020","unstructured":"J.W.M. Lenders, M.N. Kerstens, L. Amar, A. Prejbisz, M. Robledo, D. Taieb et al. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J. Hypertens. 38(8), 1443\u20131456 (2020). https:\/\/doi.org\/10.1097\/HJH.0000000000002438","journal-title":"J. Hypertens."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03205-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03205-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03205-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T09:33:33Z","timestamp":1667640813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03205-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3205"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03205-6","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"assertion":[{"value":"25 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Republic of Slovenia National Medical Ethics Committee with the reference number 0120-134\/2019.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from each patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}